Cargando…

Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease

Chronic obstructive pulmonary disease (COPD) progresses very slowly and the majority of patients are therefore elderly. COPD is characterized by an abnormal persistent inflammatory response to noxious environmental stimuli and there are increasing evidences for a close relationship between premature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Kazuhiro, Colley, Thomas, Mercado, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459652/ https://www.ncbi.nlm.nih.gov/pubmed/23055713 http://dx.doi.org/10.2147/COPD.S28250

Ejemplares similares

Geroprotectors as a therapeutic strategy for COPD – where are we now?
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2017)

Terpenoids as Potential Geroprotectors
por: Proshkina, Ekaterina, et al.
Publicado: (2020)

Genome-Protecting Compounds as Potential Geroprotectors
por: Proshkina, Ekaterina, et al.
Publicado: (2020)

Geroprotectors: A Unified Concept and Screening Approaches
por: Moskalev, Alexey, et al.
Publicado: (2017)

Astaxanthin as a Putative Geroprotector: Molecular Basis and Focus on Brain Aging
por: Sorrenti, Vincenzo, et al.
Publicado: (2020)

Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease
por: Moskalev, Alexey, et al.
Publicado: (2015)

Geroprotectors and Skeletal Health: Beyond the Headlines
por: Rayson, Alexandra, et al.
Publicado: (2022)

Assessing the Potential of Nutraceuticals as Geroprotectors on Muscle Performance and Cognition in Aging Mice
por: Singlár, Zoltán, et al.
Publicado: (2021)

Does Modulation of an Epigenetic Clock Define a Geroprotector?
por: Schork, Nicholas J., et al.
Publicado: (2022)

Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic
por: Moskalev, Alexey, et al.
Publicado: (2016)

Procaine–The Controversial Geroprotector Candidate: New Insights Regarding Its Molecular and Cellular Effects
por: Gradinaru, Daniela, et al.
Publicado: (2021)

Diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence in budding yeast
por: Leonov, Anna, et al.
Publicado: (2022)

Chain-breaking antioxidant activity of reduced forms of mitochondria-targeted quinones, a novel type of geroprotectors
por: Roginsky, Vitaly A., et al.
Publicado: (2009)

In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state
por: Aliper, Alexander, et al.
Publicado: (2016)

Large-scale chemical screen identifies Gallic acid as a geroprotector for human stem cells
por: Shan, Hezhen, et al.
Publicado: (2021)

Redox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD
por: Kiyokawa, Hirofumi, et al.
Publicado: (2021)

Caloric restriction creates a metabolic pattern of chronological aging delay that in budding yeast differs from the metabolic design established by two other geroprotectors
por: Mohammad, Karamat, et al.
Publicado: (2021)

Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
por: Triest, Filip J. J., et al.
Publicado: (2019)

Identification of Novel Therapeutic Targets in COPD
por: Mortaz, Esmaeil, et al.
Publicado: (2011)

Hypoxia in Aging and Aging-Related Diseases: Mechanism and Therapeutic Strategies
por: Wei, Yaqin, et al.
Publicado: (2022)

Novel Therapeutic Strategies for Celiac Disease
por: Asri, Nastaran, et al.
Publicado: (2020)

Aging and age‐related diseases: from mechanisms to therapeutic strategies
por: Li, Zhe, et al.
Publicado: (2021)

Current Progress of COPD Early Detection: Key Points and Novel Strategies
por: Lin, Ching-Hsiung, et al.
Publicado: (2023)

Beclin1 circulating levels and accelerated aging markers in COPD
por: Schlemmer, Frédéric, et al.
Publicado: (2018)

Role of accelerated aging in limb muscle wasting of patients with COPD
por: Lakhdar, Ramzi, et al.
Publicado: (2018)

Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
por: Schiffers, Caspar, et al.
Publicado: (2021)

Genetic predisposition to accelerated decline of lung function in COPD
por: Molfino, Néstor A
Publicado: (2007)

Advances in developing novel therapeutic strategies for Alzheimer’s disease
por: Cao, Jiqing, et al.
Publicado: (2018)

The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases
por: Kim, Byeong Mo
Publicado: (2018)

Therapeutic Approaches for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
por: Rosenwasser, Yehudis, et al.
Publicado: (2022)

Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis
por: Mirabelli, Carmen, et al.
Publicado: (2017)

Mitochondrial Transplantation as a Novel Therapeutic Strategy for Mitochondrial Diseases
por: Park, Anna, et al.
Publicado: (2021)

Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases
por: Sun, Mingchu, et al.
Publicado: (2023)

Emerging Therapeutic Options for the Management of COPD
por: Reid, Debra J., et al.
Publicado: (2013)

Strategies for improving outcomes of COPD exacerbations
por: Wilkinson, Tom, et al.
Publicado: (2006)

Telomere shortening and accelerated aging in COPD: findings from the BODE cohort
por: Elizabeth, Córdoba-Lanús, et al.
Publicado: (2017)

Targeting stress granules: A novel therapeutic strategy for human diseases
por: Wang, Fei, et al.
Publicado: (2020)

Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
por: Mutalub, Yahkub Babatunde, et al.
Publicado: (2022)

Cigarette smoke-induced impairment of autophagy in macrophages increases galectin-8 and inflammation
por: Kono, Yuta, et al.
Publicado: (2021)

Novel Antiretroviral Therapeutic Strategies for HIV
por: Cunha, Rita F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o6aifddcp95ve1ijrvaa6obkt7